Signos, Inc.
United Statesfrom the FDA registration address FDA FEI 3041000794
- Devices
- 2
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA FEI
What Signos, Inc. makes
Signos, Inc. manufactures the Signos Glucose Monitoring System, a device designed for continuous or intermittent blood glucose level tracking, intended for individuals managing diabetes or related conditions.
The company’s portfolio is regulated under Class II devices in the United States, with the Signos Glucose Monitoring System authorised via the FDA’s 510(k) pathway. The company is based in the US.
Catalogue
- Registry: GUDID
Signos Glucose Monitoring System Ref K250106
Regimes: 510(k) Registry: 510(k)
Company details
- FDA FEI number
- 3041000794
- DUNS number
- 117606123
- Address
- 30011 Ivy Glenn Dr Ste 107, Laguna Niguel, CA, 92677
Frequently asked questions
How many devices does Signos, Inc. have in the registry?
The registry currently lists 2 devices for Signos, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Signos, Inc.'s devices?
Among its 2 most recently registered devices, Signos, Inc. has devices listed in FDA 510(k) (1 device) and FDA GUDID (1 device). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Signos, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Signos, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Signos, Inc. in the registry?
The most recently registered devices listed for Signos, Inc. include Signos Glucose Management System SOTC1 and Signos Glucose Monitoring System.